The U.S. artificial ventilation and anesthesia masks market was valued at USD 540.73 million in 2024 and is poised for significant growth over the next decade. The market is projected to expand at a compound annual growth rate (CAGR) of 4.5%, reaching USD 837.72 million by 2034. This growth is driven by rising rates of respiratory disorders, increasing surgical...